Original Article
Micro-Incision
Vitreoretinal Surgery in Cases of Idiopathic Macular Hole
at a Tertiary Care Hospital
Syed
Fawad Rizwi, Muhanmmad Abdullah khan, Zeeshan Kamil, Syeda Aisha Bokhari,
Faisal Murtaza, Lubna Feroze
Pak J Ophthalmol 2017, Vol. 33, No. 3
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. .
.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for authors affiliations …..……………………….. Correspondence to: Zeeshan
Kamil Department
of Ophthalmology, L.R.B.T Free Base Eye Hospital, Korangi 21/2, Karachi Email: dr.zeeshankamil@yahoo.com |
Purpose: To assess the anatomical and visual results of micro incision vitreoretinal
surgery (MIVS) in patients with idiopathic macular hole. Study Design: Quasi experimental study. Place
and Duration of Study: LRBT Free Base Eye Hospital,
Karachi from January 2014 to December 2014. Material
and Methods: The study included 18 eyes of 18 patients
with idiopathic macular hole, who underwent MIVS with dye assisted internal
limiting membrane (ILM) peeling and 14% perfluoropropane (C3 F8)
as internal tamponade. Outcome measures were post-operative visual acuity and
anatomical closure. Post-operative follow-up was conducted up to 6 months
after the surgery. Results: Eighteen patients were recruited for the study, out of which 11
(61%) were male and 07 (39%) were female. Age ranged from 45 – 70 years (mean
age 60.8 ± 5.2 years). Visual improvement of up to 2 lines was seen in 11
(61%) of the patients, whereas, anatomical closure was achieved in 16 (88%)
of the patients. Conclusion: Micro incision vitreoretinal surgery (MIVS) in patients with
idiopathic macular hole resulted in high anatomical success and significant
visual improvement. Keywords:
Microincision vitreoretinal surgery, idiopathic macular hole,
perfluoropropane. |
Idiopathic macular hole is one of the major vitreoretinal
disorders which causes metamorphopsia and poor central vision in the elderly1.
The overall prevalence is approximately 3.3% per 10002. Numerous
causes of macular hole include myopia and trauma but most common cause is
idiopathic with a female preponderence in the 7th decade3.
It has been reported that 4-6% of full thickness macular holes close
spontaneously4. The pathogenesis of idiopathic macular hole has been
attributed to the presence of tangential and anteroposterior traction on the
fovea by pre-foveal cortical vitreous5. It has been postulated, that
the leading factors for spontaneous closure of macular hole are release of
vitreo-foveal traction or glial proliferation6. Kelly and Wendell
were the first surgeons, who report successful closure of idiopathic macular
hole7. Since then various modifications have vastly improved the
surgical outcomes, especially with the introduction of ILM peeling8 and
triamcinolone acetonide use for better visualization of the vitreous gel9.
Factors which may influence surgical outcomes include the size and duration of
macular hole, internal limiting membrane and epiretinal membrane (ERM) peeling,
type of gas tamponade used and duration of face down posturing10. The
type of internal tamponade used and the duration of face-down positioning has
been under much debate. Earlier clinical trials suggested use of long-acting
tamponade with C3F8 gas and prolonged posturing for about
2 weeks, for improvement in visual acuity and higher rates of macular hole
closure11. However, other studies recommended short-acting tamponade
with a shorter duration of face-down positioning as an effective means to
better anatomical and visual outcomes, comparable to those suggested by
previous studies12. Contrary to these beliefs, two recent studies
have suggested that for macular holes < 400 µm in size, no face-down
posturing was required13.
Success rates of up to 70% have been reported after macular hole
surgery with ERM peeling and use of SF6for internal tamponade.14Whereas,
anatomical closure of up to 90% have also been reported with vitrectomy, ILM
peeling and C3F8
gas tamponade.15
In the
current study, we assessed successful anatomical and visual outcomes of macular
hole surgery in our set up.
MATERIAL
AND METHODS
This
prospective quasi experimental study was conducted on 18 eyes of 18 patients
out of which 11 (61%) were male and 7 (39%) were female patients at LRBT Free
Base Eye Hospital Karachi from January 2014 to December 2014. All surgeries
were carried out by senior vitreo-retinal surgeon (SFR) along with assistant
surgeon (FM). The study was approved by institutional ethical review committee.
After informed consent, patients with stage 2, 3 or 4 idiopathic macular holes
were enrolled in the study. Patients with stage 1 macular hole, macular cysts
or secondary macular holes were excluded from the study. Prior to surgical
intervention, a detailed history was taken from all the patients, followed by
ophthalmic examination on biomicroscopic slit lamp using 90 diopter (D) lens,
indirect ophthalmoscopic fundoscopy with 20 D lens and visual acuity
measurement on Snellen’s chart by (MAK). Spectral domain optical coherence
tomography (OCT) was used to assess the stage of macular hole (Figure 1) by
(LF). All surgeries were performed under local peri-bulbar anesthesia with a
mixture of lidocaine (2%) and bupivacain (0.7%). A total of 2 – 3 ml was
injected. Under strict aseptic measures, micro-incision vitrectomy using 25+
guage vitrectomy system (constellation vision system, Alcon® surgicals) was
done. Surgical induction of posterior vitreous detachment (PVD) was done
followed by ILM peeling assisted by brilliant blue (BBG) staining. After
air-fluid exchange, 14% C3F8 was injected for internal
tamponade. Post-procedure, patients were advised strict face-down posturing for
2 weeks. The patients were reviewed on post-operative day 1, week 1, 6, 12 and
24. On each visit, best-corrected visual acuity (BCVA), intra-ocular pressure
and dilated fundus examination were performed. At week 6 and 24, OCT images
were also taken to establish the closure of macular hole (Figure 2). Data
collection and recording was done using SPSS statistics 21 by two of the
authors (SAB and ZK).The outcome of the surgery was assessed by the extent of
the anatomical closure of the macular hole achieved and improvement in the BCVA.
Figure 1: Pre-operative OCT (ocular coherence tomography).
Figure 2: Post-operative OCT (ocular coherence tomography).
RESULTS
Eighteen
cases of idiopathic macular hole underwent surgery at LRBT Free Base Eye
Hospital, Karachi from Jan 2014 to Dec 2014. The mean age of patients was 60.08
± 5.2 years. Among them 11 patients (61%) were male and 07 patients (39%) were
female. Pre-operative BCVA ranged from 6/18 to 6/60 or below, whereas,
postoperative BCVA at the end of 24 weeks showed improvement of 2 Snellen’s
lines or more in 61% of cases. Anatomical closure was achieved in 16 patients (88%)
of the eyes (Table 1). Paired t-test was used to analyse the data. P-value of
< 0.05 was considered to be significant.
Table 1: Indicates pre-operative
visual acuity and post-operative visual acuity at the end of 24 weeks follow
up.
Visual Acuity |
Pre-Operative |
Post-Operative (at 24 Weeks) |
6/9-6/12 |
0 |
02 (11%) |
6/18-6/24 |
02
(11%) |
02 (11%) |
6/36-6/60 |
05
(28%) |
10 (56%) |
6/60 or below |
11
(61%) |
04 (22%) |
DISCUSSION
The aim of macular hole surgery is to improve the patient’s vision
and to prevent further visual deterioration. Macular hole closure rates and
visual outcomes have improved considerably over the last decade. Important
prognostic factors include the time it takes between the onset of hole
formation to the development of an anatomical hole, and also the stage of
macular hole16.
The anatomical success rate for this study was 88%, which is
comparable to local and international studies17-19. There were 2
patients in whom anatomical success was not obtained despite surgery. These two
patients were excluded from the final result of anatomical success, and were
planned for a repeat surgery. Nadeem et al also reported the need for repeat
surgery in patients in whom anatomical closure was not achieved after the first
surgery19.
In recent times there has been an increasing trend towards ILM
peeling in macular hole surgery. ILM is the basement membrane which supports
the Muller cells. Its contraction leads to tangential tractional forces on the
macula which contributes in the pathogenesis of macular hole.10 Therefore, ILM
peeling results in relieving these forces, leading to increased surgical
success rates as demonstrated by various studies. 20Some studies have also
suggested that by relieving these tractional forces may reduce the need for
prolonged prone positioning21.
Significantly higher macular hole closure rates have also been
found in cases where dye-assisted ILM peeling was performed for both stage 2 and
stage 3 macular holes18. Initially, indocyanine green, was being
used for this purpose, but it was associated with toxic effects on
vitreomacular interface22, but now several other dyes have been
introduced. In this study Brilliant Blue was used to dye the ILM, for which no
toxic effects on retina have been reported23.
Different agents for intraocular tamponade have been used
including silicon oil and different concentrations of C3F8 gas24. In
our study we used C3F8 gas which has shown to result in good anatomical and
functional outcomes.
Significant
improvement in BCVA has been reported in many comparable studies.25,26In
current study 61% of patients showed best corrected visual improvement of more
than 2 snellen’s line at the end of 24 weeks of follow up. Other studies
have reported visual improvement in 70%
of the cases, 24, 27 whereas, Nadeem et al demonstrated an improvement of 2or
more lines in 40% of the cases and one or more line in 6.66% of the cases19.
CONCLUSION
Micro-incision
vitreo-retinal surgery with dye-assisted ILM peeling and the use of C3F8 as
internal tamponade showed satisfactory visual and anatomical outcomes. However
a larger group of operated eyes and a longer follow-up will be required to
assess the longterm effects of this procedure.
Author’s
Affiliation
Dr.
Syed Fawad Rizvi
M.B.B.S,
M.C.P.S, F.C.P.S
Prof/
Chief Consultant Ophthalmologist
L.R.B.T
Free Base Eye Hospital, Korangi 21/2, Karachi
Dr.
Mohammad Abdullah Khan
M.B;B.S,
M.C.P.S, F.C.P.S
Asst.
Prof/ Consultant Ophthalmologist
L.R.B.T
Free Base Eye Hospital, Korangi 21/2, Karachi
Dr.
Zeeshan Kamil
M.B;B.S,
M.C.P.S, F.C.P.S, F.R.C.S
Asst.
Prof/ Consultant Ophthalmologist
L.R.B.T
Free Base Eye Hospital, Korangi 21/2, Karachi
Dr.
Syeda Aisha Bokhari
M.B;B.S,
F.C.P.S, F.R.C.S
Asst.
Prof/ Ophthalmologist
L.R.B.T
Free Base Eye Hospital, Korangi 21/2, Karachi
Dr.
Faisal Murtaza
M.B;B.S,
M.C.P.S, F.C.P.S, F.R.C.S, F.C.P.S (VR)
Asst.
Prof/ Consultant Ophthalmologist
L.R.B.T
Free Base Eye Hospital, Korangi 21/2, Karachi
Dr. LubnaFeroz
M.B;B.S,
Medical Officer
L.R.B.T
Free Base Eye Hospital, Korangi 21/2, Karachi
Role of authors
Dr.
Syed Fawad Rizvi
Senior
Vitreo-retinal surgeon
Dr.
Mohammad Abdullah Khan
Patient
Clinical Assessment
Dr.
Zeeshan Kamil
Data
collection and recording
Dr.
Syeda Aisha Bokhari
Data
collection and recording
Dr.
Faisal Murtaza
Data
collection and recording
Dr.
Lubna Feroz
OCT
conductor
REFERENCES
1.
Jackson TL, Donochie PH, Sparrow JM et al. United Kingdom National Ophthalmology Database Study of vitreoretinal
surgery: Report 2, macular hole. Ophthalmology, 2013; 120: 629-634.
2.
Fine S.
Discussion, macular holes. Ophthalmology, 1993; 100: 871.
3.
Margherio RR, Schepens CL. Macular breaks. I. Diagnosis, etiology and observations. Am J
Ophthalmol. 1972; 74: 233-40.
4.
Inoue M, Arakawa A, Yamane S et al. Long-term outcome of macular microstructure assessed by ocular
coherence tomography in eyes with spontaneous resolution of macular hole. Am J
Ophthalmol. 2012; 153: 687-91.
5.
Khaqan HA, Jameel F et al. Visual outcomes of macular hole surgery, J Coll Physicians Surg
Pak. 2016; 26 (10): 839-42.
6.
Lo WR, Hubbard JB.
Macular hole formation, spontaneous closure, and recurrence in a previously
vitrectomized eye. A J Ophthalmol. 2006; 141: 962-4.
7.
Kelly NE, Wendel RT:
Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch
Ophthalmol. 1991; 109: 654-659.
8.
Park DW, Sipperly JO, Sneed SR et al. Macular hole surgery with internal limiting membrane peeling and
intravitreous air. Ophthalmology, 1999; 106: 1392-1397.
9.
Sakamoto T, Ishibashi T: visualizing vitreous in vitrectomy by triamcinolone. Graefes Arch
Clin Exp Ophthalmol. 2009; 247: 1153-1163.
10.
Kumar A, Gogia V, Kumar P et al. Evaluation of predictors for anatomical success in macular hole
surgery in Indian population. Indian J Ophthalmol. 2014 Dec; 62 (12):
1141-1145.
11.
Thompson JT, Smiddy WE, Glaser BM et al. Intraocular tamponade duration and success of macular hole
surgery. Retina, 1996; 16: 373-382.
12.
Tadayoni R, Vicaut E, Devin F et al. A randomized controlled trial of alleviated positioning after
small macular hole surgery. Ophthalmology, 2011; 118: 150-155.
13.
Guillaubey A, Malvitte L, Lafontaine PO et al. Comparison of face down and seated position after idiopathic
macular hole surgery: a randomized clinical trial. Am J Ophthalmol. 2008; 146:
128-134.
14.
Wendel RT, Patel AC, Kelly NE et al. Vitreous surgery for macular holes. Ophthalmology, 1993; 100:
1671-6.
15.
Kumar A. Gogia V, Shah VM et al. Comparative evaluation of anatomical and functional outcomes
using brilliant blue G versus triamcinolone assisted ILM peeling in macular
hole surgery in Indian population. Graefes Arch Clin Exp Ophthalmol. 2011; 249:
987-995.
16.
Kang HK, Chang AA and Beaument PE. The macular hole: report of an Australian surgical series and
meta-analysis of the literature. Clin Exp Ophthalmol. 2008; 28: 298-308.
17.
Gupta B, Laidlaw DAH, Williamson TH et al. Predicting visual success in macular hole surgery. Br J
Ophthalmol. 2009; 3: 1488-91.
18.
Christenson US, Kroyer K, Sander B et al. Value of internal limiting membrane peeling for surgery for
idiopathic macular hole stage 2 and 3: a randomized clinical trial. Br J
Ophthalmol. 2009; 93: 1005-15.
19.
Ahmed N, Shah SRA, Choudry QL et al. Outcomes of macular hole surgery at Mayo Hospital, Lahore. Pak J
Ophthalmol. 2012; 28 (2): 77-80.
20.
Lois N, Burr J, Norrie J, et al. Full-thickness Macular Hole and Internal Limiting Membrane
Peeling Study (FILMS) Group. Internal-limiting membrane peeling versus no
peeling for idiopathic full-thickness macular hole: a pragmatic randomized
controlled trial. Invest Ophthalmol Vis Sci. 2011; 52 (3): 1586-1592.
21.
Wickens JC, Shah GK.
Outcomes of macular hole surgery and shortened face-down positioning. Retina,
2006; 26: 902-4.
22.
Gandorfer A, Haritoglou C, Kampik A. Retinal damage from indocyanine green in experimental macular
surgery. Invest Ophthalmol Vis Sci. 2003; 44 (1): 316-323.
23.
Enaida H, Hisatomi T, Goto Y et al. Pre-clinical investigation of internal limiting membrane peeling
and staining using intravitreal brilliant blue G. Retina, 2006; 26 (6):
623-630.
24.
Ivanoska-AAdjievska B, Boskurt S, Semiz F, et al. Treatment of idiopathic macular hole with silicone oil tamponade.
Clinical Ophthalmology, 2012; 6: 1449-1454.
25.
Chang LK, Koizumi H, Spaide RF. Disruption of the photoreceptor inner segment-outer segment
junction in eyes with macular holes. Retina, 2008; 28: 969-75.
26.
Oh J, Smiddy WE, Flynn HW Jr, et al. Photoreceptor inner/outer segment defect imaging by spectral
domain OCT and visual prognosis after macular hole surgery. Invest Ophthalmol
Vis Sci. 2010; 51: 1651-1658.
27.
Khokhar AR, Faziur Rabb K, Akhtar HU. Outcomes of macular hole surgery. J Coll Physicians Surg Pak.
2003; 13: 569-72.